Literature DB >> 34161371

The Science for Profit Model-How and why corporations influence science and the use of science in policy and practice.

Tess Legg1, Jenny Hatchard1, Anna B Gilmore1.   

Abstract

Science has been at the centre of attempts by major industries, including tobacco, chemical, and pharmaceutical, to delay progress in tackling threats to human and planetary health by, inter alia, obscuring industry harms, and opposing regulation. Some aspects of this influence are well documented, others remain poorly understood, and similarities between industries remain underexplored. This study, therefore, aims to synthesise the literature to develop an evidence-based typology and model of corporate influence on science in order to provide an overview of this multi-faceted phenomenon. We obtained literature examining corporate attempts to influence science and the use of science in policy and practice from: database searches, bibliographies, expert recommendations, and web alerts; using a modified scoping review methodology (n = 68). Through interpretive analysis we developed the Science for Profit Typology and Model. We identified eight corporate sectors repeatedly engaging in activities to influence science, including: manipulation of scientific methods; reshaping of criteria for establishing scientific "proof"; threats against scientists; and clandestine promotion of policy reforms that increase reliance on industry evidence. The typology identifies five macro-level strategies used consistently across the eight industries, comprising 19 meso-level strategies. The model shows how these strategies work to maximise the volume, credibility, reach, and use of industry-favourable science, while minimising these same aspects of industry-unfavourable science. This creates doubt about harms of industry products/practices or efficacy of policies affecting industry; promotes industry-favoured policy responses and industry products as solutions; and legitimises industry's role as scientific stakeholder. These efforts ultimately serve to weaken policy, prevent litigation, and maximise use of industry products/practices-maximising corporate profitability. We provide an accessible way to understand how and why corporations influence science, demonstrate the need for collective solutions, and discuss changes needed to ensure science works in the public interest.

Entities:  

Year:  2021        PMID: 34161371     DOI: 10.1371/journal.pone.0253272

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  2 in total

1.  Commercial use of evidence in public health policy: a critical assessment of food industry submissions to global-level consultations on non-communicable disease prevention.

Authors:  Kathrin Lauber; Darragh McGee; Anna B Gilmore
Journal:  BMJ Glob Health       Date:  2021-08

2.  Clearing the Air: Conflicts of Interest and the Tobacco Industry's Impact on Indigenous Peoples.

Authors:  Raglan Maddox; Michelle Kennedy; Andrew Waa; Ali Drummond; Billie-Jo Hardy; Claradina Soto; El-Shadan Tautolo; Emily Colonna; Heather Gifford; Hershel Clark; Juliet P Lee; Patricia Nez Henderson; Penney Upton; Shane Kawenata Bradbrook; Shavaun Wells; Sydney A Martinez; Tom Calma
Journal:  Nicotine Tob Res       Date:  2022-04-28       Impact factor: 5.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.